TR200200169T2 - IL-18 inhibitörlerinin kullanımı. - Google Patents

IL-18 inhibitörlerinin kullanımı.

Info

Publication number
TR200200169T2
TR200200169T2 TR2002/00169T TR200200169T TR200200169T2 TR 200200169 T2 TR200200169 T2 TR 200200169T2 TR 2002/00169 T TR2002/00169 T TR 2002/00169T TR 200200169 T TR200200169 T TR 200200169T TR 200200169 T2 TR200200169 T2 TR 200200169T2
Authority
TR
Turkey
Prior art keywords
inhibitors
tumor metastasis
metastasis
tumor
Prior art date
Application number
TR2002/00169T
Other languages
Unknown language ( )
English (en)
Turkish (tr)
Inventor
Dinarello Charles
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of TR200200169T2 publication Critical patent/TR200200169T2/

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/00169T 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı. TR200200169T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors

Publications (1)

Publication Number Publication Date
TR200200169T2 true TR200200169T2 (tr) 2002-06-21

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00169T TR200200169T2 (tr) 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı.

Country Status (31)

Country Link
US (1) US7741276B2 (OSRAM)
EP (1) EP1206274B1 (OSRAM)
JP (1) JP4827352B2 (OSRAM)
KR (1) KR100682219B1 (OSRAM)
CN (1) CN1173736C (OSRAM)
AR (1) AR024907A1 (OSRAM)
AT (1) ATE363288T1 (OSRAM)
AU (1) AU782478B2 (OSRAM)
BG (1) BG65800B1 (OSRAM)
BR (1) BR0012675A (OSRAM)
CA (1) CA2380216C (OSRAM)
CY (1) CY1107932T1 (OSRAM)
CZ (1) CZ302114B6 (OSRAM)
DE (2) DE1206274T1 (OSRAM)
DK (1) DK1206274T3 (OSRAM)
EA (1) EA005419B1 (OSRAM)
EE (1) EE04838B1 (OSRAM)
ES (1) ES2186596T3 (OSRAM)
HK (1) HK1048248B (OSRAM)
HU (1) HU228780B1 (OSRAM)
IL (2) IL131047A0 (OSRAM)
MX (1) MXPA02000838A (OSRAM)
NO (1) NO329827B1 (OSRAM)
NZ (1) NZ516535A (OSRAM)
PL (1) PL202477B1 (OSRAM)
PT (1) PT1206274E (OSRAM)
SK (1) SK287522B6 (OSRAM)
TR (1) TR200200169T2 (OSRAM)
UA (1) UA73745C2 (OSRAM)
WO (1) WO2001007480A2 (OSRAM)
ZA (1) ZA200200390B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300423A3 (en) 2000-02-10 2008-07-28 Abbott Lab Antibodies that bind human interleukin-18 and methods of making and using
WO2002031115A2 (en) 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
EP1425028B1 (en) * 2001-05-16 2009-12-16 Yeda Research And Development Co. Ltd. Use of il-18 inhibitors for the treatement or prevention of sepsis
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
BR0315155A (pt) * 2002-10-08 2005-08-16 Ares Trading Sa Uso de citocina capaz de ligar il-18bp e de inibir a atividade de uma segunda citocina
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
PT2267024E (pt) 2005-06-03 2012-06-01 Ares Trading Sa Produção de proteína de ligação a il-18 recombinante
ATE529433T1 (de) 2005-06-10 2011-11-15 Ares Trading Sa Verfahren zur reinigung eines il-18-bindenden proteins
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
KR20240144422A (ko) 2022-03-15 2024-10-02 컴퓨젠 엘티디. 암 치료의 단독치료법 및 병용치료법에서 il-18bp 길항제 항체 및 이의 용도
KR20250133728A (ko) 2023-01-06 2025-09-08 라센 테라퓨틱스, 인코포레이티드 항-il-18bp 항체
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Il—18bp拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ256171A (en) * 1992-09-02 1996-12-20 Isis Pharmaceuticals Inc Treating diseases amenable to treatment through modulating intercellular adhesion molecule metabolism or synthesis using oligonucleotides
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
EP0998300A1 (en) * 1997-03-18 2000-05-10 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
EE200200032A (et) 2003-02-17
AU782478B2 (en) 2005-08-04
HK1048248A1 (en) 2003-03-28
IL131047A0 (en) 2001-01-28
ES2186596T1 (es) 2003-05-16
NO20020153D0 (no) 2002-01-11
BG65800B1 (bg) 2009-12-31
NZ516535A (en) 2004-04-30
ATE363288T1 (de) 2007-06-15
CA2380216A1 (en) 2001-02-01
KR100682219B1 (ko) 2007-02-12
CY1107932T1 (el) 2013-09-04
DE60035049T2 (de) 2007-09-27
WO2001007480A3 (en) 2001-05-10
UA73745C2 (en) 2005-09-15
CZ302114B6 (cs) 2010-10-20
IL147675A (en) 2009-05-04
US7741276B2 (en) 2010-06-22
KR20020027493A (ko) 2002-04-13
EP1206274A2 (en) 2002-05-22
BG106311A (en) 2002-08-30
US20080003216A1 (en) 2008-01-03
JP4827352B2 (ja) 2011-11-30
CN1173736C (zh) 2004-11-03
MXPA02000838A (es) 2002-07-30
WO2001007480A2 (en) 2001-02-01
EP1206274B1 (en) 2007-05-30
CA2380216C (en) 2012-01-31
EE04838B1 (et) 2007-06-15
EA005419B1 (ru) 2005-02-24
BRPI0012675B1 (pt) 2001-02-01
NO20020153L (no) 2002-03-11
HUP0202107A3 (en) 2005-01-28
CZ2002195A3 (cs) 2002-06-12
PT1206274E (pt) 2007-07-06
ES2186596T3 (es) 2007-11-16
BR0012675A (pt) 2002-04-09
EA200200189A1 (ru) 2002-12-26
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
DE1206274T1 (de) 2002-11-14
BRPI0012675B8 (OSRAM) 2021-05-25
DE60035049D1 (de) 2007-07-12
HUP0202107A2 (en) 2002-10-28
DK1206274T3 (da) 2007-08-13
HU228780B1 (en) 2013-05-28
CN1364086A (zh) 2002-08-14
SK882002A3 (en) 2002-07-02
PL202477B1 (pl) 2009-06-30
SK287522B6 (sk) 2011-01-04
AU5843200A (en) 2001-02-13
PL353732A1 (en) 2003-12-01
ZA200200390B (en) 2003-04-30
NO329827B1 (no) 2011-01-03
AR024907A1 (es) 2002-10-30

Similar Documents

Publication Publication Date Title
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60010098D1 (de) 28-epirapaloge
TR200102711T2 (tr) Kriz halindeki başağrılarının iyileştirilmesinde kullanıma yönelik antikonvülsan türevler
IS6217A (is) Mótefnissameindir með sérvirkni fyrir alfa æxlisdrepboða í mönnum og notkun þeirra
UY27972A1 (es) Derivados de hidantoína
NO20025442L (no) Brachyterapi kilde
DE60002193D1 (de) Metalloprotease inhibitoren
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
NO20014243L (no) Dihetero-substituerte metalloproteaseinhibitorer
DE59806475D1 (de) Urokinase-inhibitoren
PT1242410E (pt) Compostos novos
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
DE60106850D1 (de) Wälzschleifen von nichtmetallischen Zahnrädern
BR0316544A (pt) Compostos calcilìticos
NO20005548L (no) Mykobakterieinhibitorer
AU302730S (en) Bed
DE50311665D1 (de) Guanidinophenylalanin-verbindungen als urokinase-inhibitoren
NO20015922L (no) Nye calpainer og anvendelse derav
ATE433953T1 (de) Peptiddeformylaseinhibitoren
UA50030A (uk) Комплексне добриво
SE0004239D0 (sv) New use of an inhibitor
ECSP982458A (es) Aplicación oral de (+)-o- demetiltramadol como analgesico
SE0101231D0 (sv) Novel use of proton pump inhibitors